Long-Acting Injectable Antipsychotics and Risk of Hospitalization
Brian Holoyda, MD. Dr. Holoyda has no financial relationships with companies related to this material.
Brian Holoyda, MD. Dr. Holoyda has no financial relationships with companies related to this material.
José S. Sanchez-Cruz, MD. Chief Resident, Department of Psychiatry, NYU Langone Health, New York. Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.
Dr. Sanchez-Cruz and Dr. Aiken have no financial relationships with companies related to this material.
Jeffrey Cardenas, MD. Dr. Cardenas has no financial relationships with companies related to this material.
Kristin Cadenhead, MD.
Professor of psychiatry. Director, Cognitive Assessment and Risk Evaluation (CARE) Early Psychosis Treatment and Research Program, University of California, San Diego.
Dr. Cadenhead has no financial relationships with companies related to this material.
Brian Miller, MD, PhD, MPH. Dr. Miller, author of this educational activity, receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.
Brian Miller, MD, PhD, MPH. Dr. Miller, author of this educational activity, receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.
Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.
© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.